Nektar Therapeutics
NKTR
NKTR
387 hedge funds and large institutions have $9.73B invested in Nektar Therapeutics in 2018 Q3 according to their latest regulatory filings, with 55 funds opening new positions, 177 increasing their positions, 107 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
3% more funds holding
Funds holding: 377 → 387 (+10)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
0.07% less ownership
Funds ownership: 6.24% → 6.17% (-0.07%)
Holders
387
Holding in Top 10
6
Calls
$225M
Puts
$155M
Top Buyers
| 1 | +$80.5M | |
| 2 | +$53.9M | |
| 3 | +$43.1M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$40.3M |
| 5 |
State Street
Boston,
Massachusetts
|
+$37.1M |
Top Sellers
| 1 | -$109M | |
| 2 | -$45.6M | |
| 3 | -$42.6M | |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$39.3M |
| 5 |
Millennium Management
New York
|
-$37.8M |